APTALIS PHARMA INC Selling, General and Administrative Expense
APTALIS PHARMA INC reported Selling, General and Administrative Expense of $33.27 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-02-10
- APTALIS PHARMA INC selling, general and administrative expense for the quarter ending 2011-12-31 was $33.27M, a 32.16% increase year-over-year.
- APTALIS PHARMA INC selling, general and administrative expense for the quarter ending 2011-09-30 was $39.63M, a 52.52% increase year-over-year.
- APTALIS PHARMA INC selling, general and administrative expense for the quarter ending 2011-06-30 was $39.26M, a 43.63% increase year-over-year.
- APTALIS PHARMA INC selling, general and administrative expense for the quarter ending 2010-12-31 was $25.17M.
- APTALIS PHARMA INC selling, general and administrative expense for fiscal 2011 was $143.10M, a 25.57% increase from fiscal 2010.
- APTALIS PHARMA INC selling, general and administrative expense for fiscal 2010 was $113.96M, a 7.30% decline from fiscal 2009.
- APTALIS PHARMA INC selling, general and administrative expense for fiscal 2009 was $122.94M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $33.27M 10-Q · filed 2012-02-10 | $72.89M derived: sum of 2 quarters · filed 2012-02-10 | $112.16M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2011-09-30 | $39.63M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $78.89M derived: sum of 2 quarters · filed 2011-12-20 | $143.10M 10-K · filed 2011-12-20 | |
| 2011-06-30 | $39.26M 10-Q · filed 2011-08-12 | $103.47M 10-Q · filed 2011-08-12 | ||
| 2010-12-31 | $25.17M 10-Q · filed 2012-02-10 | $51.15M derived: sum of 2 quarters · filed 2012-02-10 | $78.49M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2010-09-30 | $25.98M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $53.32M derived: sum of 2 quarters · filed 2011-12-20 | $113.96M 10-K · filed 2011-12-20 | |
| 2010-06-30 | $27.34M 10-Q · filed 2011-08-12 | $87.98M 10-Q · filed 2011-08-12 | ||
| 2009-09-30 | $122.94M 10-K · filed 2011-12-20 |